Skip to main content
رجوع
SION logo

Sionna Therapeutics, Inc.

جودة البيانات: 100%
SION
NASDAQ Healthcare Biotechnology
KWD 37.08
▲ KWD 2.32 (6.67%)
القيمة السوقية: 1.67B
نطاق اليوم
KWD 34.95 KWD 38.20
نطاق 52 أسبوعًا
KWD 7.26 KWD 45.00
حجم التداول
284,096
متوسط 50 يوم / 200 يوم
KWD 38.16 / KWD 30.86
الإغلاق السابق
KWD 34.76

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -22.2 0.3
P/B 5.4 3.0
ROE % -105.2 3.7
Net Margin % 3.8
Rev Growth 5Y % 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

Hold
KWD 46.25 +24.7%
Low: KWD 24.00 High: KWD 58.00
ربحية السهم المستقبلية
-KWD 2.33
الإيرادات المقدّرة
0.0

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 -KWD 2.51
-KWD 2.51 – -KWD 2.51
73.67M 5
FY2029 -KWD 2.78
-KWD 2.78 – -KWD 2.78
32.60M 2
FY2028 -KWD 3.08
-KWD 4.05 – -KWD 1.71
4.29M 7

Earnings Surprises

Last 6 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-02 -KWD 0.54 -KWD 0.46 +14.7%
2025-11-05 -KWD 0.52 -KWD 0.46 +11.5%
2025-08-11 -KWD 0.68 -KWD 0.41 +39.7%
2025-05-12 -KWD 0.45 -KWD 0.62 -37.8%
2025-03-20 -KWD 0.57 -KWD 3.38 -493.0%
2024-11-27 N/A -KWD 0.92

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -66.67M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-105.18%
ROIC-21.15%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.03
Current Ratio20.61
Interest Coverage0.00

التقييم

P/E Ratio
-22.17
Forward P/EN/A
P/B Ratio5.44
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -75.27M
ROE -105.18% ROA -23.09%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -66.67M
ROIC -21.15% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.03 Current Ratio 20.61
Interest Coverage 0.00
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -22.17 Forward P/E N/A
P/B Ratio 5.44 P/S Ratio N/A
PEG Ratio -0.64 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -4.00%
Market Cap 1.67B Enterprise Value 1.62B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 0.0 0.0 0.0 0.0
Net Income -75.27M -61.69M -47.26M -40.24M
EPS (Diluted) -1.88 -1.40 -1.07 -0.91
Gross Profit -647,000.0 -668,000.0 0.0 0.0
Operating Income -88.98M -70.56M -50.33M -41.37M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 325.95M 185.75M 51.95M 87.37M
Total Liabilities 19.12M 349.47M 166.83M 157.29M
Shareholders' Equity 306.83M -163.71M -114.88M -69.92M
Total Debt 8.68M 9.75M 10.48M 0.0
Cash & Equivalents 58.45M 37.79M 38.52M 54.84M
Current Assets 241.42M 150.99M 39.21M 83.83M
Current Liabilities 11.71M 10.42M 8.04M 8.25M